Valuation: RUA Life Sciences plc

Capitalization 8.07M 9.84M 9.56M 8.99M 14.17M 852M 15.83M 110M 40.67M 350M 36.88M 36.13M 1.54B P/E ratio 2025 *
-8.13x
P/E ratio 2026 * 18.6x
Enterprise value 4.97M 6.06M 5.88M 5.54M 8.72M 524M 9.75M 67.61M 25.05M 215M 22.71M 22.25M 947M EV / Sales 2025 *
1.52x
EV / Sales 2026 * 1x
Free-Float
46.64%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+8.33%
1 week+8.33%
Current month+18.18%
1 month+18.18%
3 months-8.77%
6 months+18.18%
Current year+18.18%
More quotes
1 week
11.50
Extreme 11.5
13.90
1 month
10.33
Extreme 10.33
13.90
Current year
10.33
Extreme 10.33
13.90
1 year
8.50
Extreme 8.5
15.70
3 years
8.50
Extreme 8.5
67.00
5 years
8.50
Extreme 8.5
180.00
10 years
8.00
Extreme 8
180.00
More quotes
Director TitleAgeSince
Chief Executive Officer 56 18/06/2024
Director of Finance/CFO - 30/11/2021
Chief Executive Officer 72 30/10/2016
Manager TitleAgeSince
Director/Board Member 72 30/10/2016
Director/Board Member 74 -
Chairman 69 18/06/2024
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+8.33%+8.33%+3.17%-79.20%9.84M
-0.37%+3.20%+3.78%-5.91%214B
+1.47%+8.25%+65.14%+92.58%211B
-1.46%+1.40%+6.14%-18.73%172B
+0.50%+3.98%+61.84%+119.93%145B
+2.24%+1.28%-0.84%-12.46%60.06B
+1.82%+7.19%+15.02%+1.85%42.09B
-0.11%-4.96%-5.47%-40.99%41.16B
-0.31%-0.02%+16.48% - 38.72B
-0.29%+1.23%-13.23%-30.59%38.61B
Average +1.18%+2.91%+15.20%+2.94% 96.34B
Weighted average by Cap. +0.24%+3.59%+26.05%+31.31%
See all sector performances

Financials

2025 *2026 *
Net sales 3.26M 3.97M 3.86M 3.63M 5.72M 344M 6.39M 44.35M 16.43M 141M 14.9M 14.59M 621M 4.27M 5.21M 5.06M 4.76M 7.51M 451M 8.38M 58.17M 21.55M 185M 19.54M 19.14M 814M
Net income -992K -1.21M -1.18M -1.11M -1.74M -105M -1.95M -13.5M -5M -43M -4.54M -4.44M -189M 435K 530K 515K 485K 764K 45.92M 853K 5.92M 2.19M 18.86M 1.99M 1.95M 82.88M
Net Debt -3.1M -3.78M -3.67M -3.45M -5.44M -327M -6.08M -42.19M -15.63M -134M -14.17M -13.88M -591M -3.8M -4.63M -4.5M -4.23M -6.67M -401M -7.45M -51.72M -19.16M -165M -17.37M -17.02M -724M
More financial data * Estimated data
Logo RUA Life Sciences plc
RUA Life Sciences plc is a United Kingdom-based holding company of a group of medical device businesses focused on the exploitation of long-term implantable biostable polymer (Elast-Eon). Elast-Eon's biostability is comparable to silicone while exhibiting excellent mechanical, blood contacting and flex-fatigue properties. The Company has four business units: RUA Contract Manufacture, RUA Biomaterials, RUA Vascular and RUA Structural Heart. RUA Contract Manufacture is an end-to-end contract developer and manufacturer of medical devices and implantable fabric specialist. It provides sub-contract manufacturing, assembly, packing and services to the medical device sector from its Class 7 and 8 cleanroom suites. RUA Biomaterials is a licensor of Elast-Eon polymers to the medical device industry. RUA Vascular is engaged in the commercialization of open surgical vascular grafts and patches. RUA Structural Heart is engaged in the development of polymeric leaflet systems for heart valves.
Employees
40
More about the company
Date Price Change Volume
17/01/25 13.00 p +8.33% 291,527
16/01/25 12.00 p 0.00% 302,184
15/01/25 12.00 p 0.00% 48,679
14/01/25 12.00 p 0.00% 42,932
13/01/25 12.00 p 0.00% 183,413

Delayed Quote London S.E., January 17, 2025 at 04:35 pm

More quotes
Trading Rating
Investor Rating
ESG MSCI
surperformance-ratings-light-chart RUA-LIFE-SCIENCES-PLCMore Ratings

Annual profits - Rate of surprise